Arie Barlev - Atara Biotherapeutics | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 62 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Comparative Analysis of Tabelecleucel and Current Treatment in Patients with Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease Following Hematopoietic Cell Transplant or Solid Organ Transplant

Arie Barlev,Heiner Zimmermann,Norma Guzman-Becerra,Aditi Mehta,Baodong Xing,Berengere Macabeo, Marion Thivolet, M. Alan Brookhart

JOURNAL OF MEDICAL ECONOMICSno. 1 (2024): 789-795

引用0浏览0WOS引用

Outcomes for Patients with EBV-positive PTLD Post-Allogeneic HCT after Failure of Rituximab-Containing Therapy

Gérard Socié,Pere Barba,Arie Barlev,Jaime Sanz,Irene García-Cadenas,Patrice Chevallier,Franca Fagioli,Norma Guzman-Becerra,Deepali Kumar,Per Ljungman,Arnaud Pigneux,Natalia Sadetsky,Lucrecia Yáñez San Segundo,Mazyar Shadman,Jan Storek,Dhanalakshmi Thirumalai,Baodong Xing,Mohamad Mohty

BONE MARROW TRANSPLANTATIONno. 1 (2024): 52-58

引用1浏览0WOSNATURE引用

Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021

Crystal Watson,Dhanalakshmi Thirumalai,Arie Barlev,Eddie Jones,Sasha Bogdanovich,Kiren Kresa-Reahl

Neurology and therapy（2023）

引用0浏览0WOS引用

A Fully Enrolled, Novel, Patient-Centred Real-World Evidence Study Designed to Better Understand Active and Nonactive Progressive Multiple Sclerosis Using Health Records in the United States

Crystal Watson,Kiren Kresa-Reahl,Sasha Bogdanovich, Nathaniel Phillips,Kieran Mace, Seth Colbert-Pollack,Haley S. Friedler,Gillian Hanson,Arie Barlev

MULTIPLE SCLEROSIS JOURNAL（2023）

引用0浏览0引用

Physician-reported Cognitive Symptoms in Patients with Active and Nonactive Primary or Secondary Progressive Multiple Sclerosis in a Cross-Sectional Survey in the United States

Jiahe Chen,Crystal Watson,Dhanalakshmi Thirumalai,Arie Barlev,Eddie Jones,Sasha Bogdanovich

MULTIPLE SCLEROSIS JOURNAL (2023): 1029-1029

引用0浏览0引用

Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May Be Inappropriate: A Modified Delphi Study

Sridhar Chaganti,Arie Barlev,Sophie Caillard,Sylvain Choquet,Kate Cwynarski,Anke Friedetzky,Eva González-Barca,Natalia Sadetsky,Stefan Schneeberger,Dhanalakshmi Thirumalai,Pier L. Zinzani,Ralf U. Trappe

Advances in therapy（2023）

引用0浏览0WOS引用

Clinical Outcomes of Solid Organ Transplant (SOT) Patients with Epstein-Barr Virus-Driven (EBV⁺) Post-Transplant Lymphoproliferative Disease (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study

V. Dharnidharka,D. Thirumalai,U. Jaeger,W. Zhao,D. Dierickx,P. Xun, P. Minga,A. Sawas,N. Sadetsky,P. Chauvet, E. Sundaram,A. Barlev,H. Zimmermann,R. U. Trappe

Blood（2022）

引用3浏览0引用

A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimen

Crystal Watson,Hemanth Gadikota,Arie Barlev,Rachel Beckerman

JOURNAL OF DRUG ASSESSMENTno. 1 (2022): 1-11

引用3浏览0WOS引用

Mean Lifetime Survival Estimates Following Solid Organ Transplantation in the US and UK

Christopher N. Graham,Crystal Watson,Arie Barlev,Matt Stevenson,Vikas R. Dharnidharka

Journal of medical economicsno. 1 (2022): 230-237

引用12浏览0WOS引用

Results from Patient Interviews on Fatigue in Progressive Multiple Sclerosis and Evaluation of Fatigue Patient-Reported Outcome (PRO) Instruments

Watson Crystal,Scippa Kayla,Barlev Arie,Kresa-Reahl Kiren,Cole Jason C.

Neurology and Therapy（2022）

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn